C. Hammer

发表

Towards a rational approach for heavy-atom derivative screening in protein crystallography.

P. Sun, M. Joyce, J. Agniswamy, 2008, Acta crystallographica. Section D, Biological crystallography.

Interactions of the Vaccinia Virus A19 Protein

B. Moss, Ming Zhao, P. S. Satheshkumar, 2013, Journal of Virology.

Identification of conserved antigens for early serodiagnosis of relapsing fever Borrelia

T. Schwan, S. Porcella, M. E. Schrumpf, 2009, Microbiology.

C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.

G. Nilsson, A. Siegbahn, D. Metcalfe, 1996, Journal of immunology.

The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.

K. Joiner, E. Brown, M. Frank, 1983, Journal of immunology.

Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitor.

M. Frank, C. Hammer, L. Prograis, 1987, Journal of immunological methods.

Complement receptor expression by neoplastic and normal human cells.

I. Magrath, M. Frank, M. Berger, 1983, Journal of immunology.

Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection

Adeline R. Whitney, F. DeLeo, B. Kreiswirth, 2007, Cellular microbiology.

Production and characterization of the monoclonal antibody against SGP120, a novel serum protein.

M. Frank, C. Hammer, V. Miletić, 1996, Hybridoma.

A simplified method for purification of human C5a from citrated plasma.

K. Yancey, M. Frank, T. Lawley, 1986, Journal of immunological methods.

Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.

M. Shin, S. Kim, C. Hammer, 1987, Journal of immunology.

Studies of human C5a as a mediator of inflammation in normal human skin.

K. Yancey, M. Frank, T. Lawley, 1985, The Journal of clinical investigation.

[7] The third, fourth, and fifth components of human complement: Isolation and biochemical properties

R. Harrison, Matthew L. Thomas, J. Janatova, 1981 .

On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.

M. Shin, A. Abramovitz, M. Mayer, 1977, Journal of immunology.

A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.

E. Brown, M. Frank, C. Hammer, 1982, The Journal of clinical investigation.

Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.

K. Joiner, D. Sacks, R. D. da Silva, 1990, Journal of immunology.

Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.

M. Shin, C. Hammer, D. F. Carney, 1986, Journal of immunology.

Release of arachidonic acid and formation of oxygenated derivatives after complement attack on macrophages: role of channel formation.

D. Imagawa, M. Mayer, L. Ramm, 1986, Journal of immunology.

A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.

K. Joiner, M. Frank, L. Leive, 1984, Journal of immunology.

Potassium cyanide protects Escherichia coli from complement killing by the inhibition of C3 convertase activity.

K. Joiner, M. Rahbar, C. Hammer, 1993, Immunological investigations.

Studies of Human C 5 a as a Mediator of Inflammation in Normal Human Skin

K. Yancey, M. Frank, T. Lawley, 2022 .

Inhibition of complement by culture supernatants of Aspergillus fumigatus.

J. Bennett, C. Hammer, R. Washburn, 1986, The Journal of infectious diseases.

Further identification of human plasma glycoproteins interacting with the galactose-specific lectin Jacalin.

C. Hammer, G. Rostoker, M. Basta, 1995, Journal of chromatography. B, Biomedical applications.

Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.

K. Joiner, J. Schweinle, M. Frank, 1989, The Journal of clinical investigation.

C3 binding but not its breakdown is affected by the structure of lipopolysaccharide (LPS) on the surface of Salmonellae

K. Joiner, L. Leive, C. Hammer, 1984 .

Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases.

A. Sher, K. Joiner, T. Kipnis, 1988, The Journal of biological chemistry.

A new simplified procedure for C1 inhibitor purification. A novel use for jacalin-agarose.

M. Frank, L. Fries, C. Hammer, 1989, Journal of immunological methods.

Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.

K. Joiner, M. Frank, J. Foulds, 1987, Journal of immunology.

Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

K. Joiner, M. Frank, M. Sanders, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease.

G. Tsokos, M. Frank, J. Balow, 1986, The Journal of allergy and clinical immunology.

Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities.

G. Tsokos, M. Frank, J. Balow, 1986, The Journal of allergy and clinical immunology.

Large scale isolation of functionally active components of the human complement system.

H. Gresham, B. Tack, C. Hammer, 1981, The Journal of biological chemistry.

Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor.

M. Frank, L. Fries, C. Hammer, 1988, The Journal of allergy and clinical immunology.

Complement and Complement Reactions

H. Colten, O. Götze, P. Schneider, 1988 .

Characterization of a lysyl aminopeptidase activity associated with phosphoglucose isomerase of Vibrio vulnificus.

G. Richards, S. Parveen, C. Hammer, 2004, Biochimica et biophysica acta.

C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I

M. Frank, L. Fries, C. Hammer, 1984, The Journal of experimental medicine.

Comparative sialomics between hard and soft ticks: implications for the evolution of blood-feeding behavior.

J. Andersen, J. Ribeiro, T. Schwan, 2008, Insect biochemistry and molecular biology.

Generation of C5-dependent bioactivity by tissue-bound anti-BMZ autoantibodies.

K. Yancey, C. Hammer, W. Gammon, 1989, The Journal of investigative dermatology.

The action of bromine on ?7-ergostene and choletene derivatives

C. Hammer, 1965 .

In Vitro Proteolytic Processing of the MD145 Norovirus ORF1 Nonstructural Polyprotein Yields Stable Precursors and Products Similar to Those Detected in Calicivirus-Infected Cells

G. Belliot, K. Green, C. Hammer, 2003, Journal of Virology.

Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.

B. Murphy, M. Frank, L. Fries, 1988, Virology.

Identification of a Novel Staphylococcus aureus Two-Component Leukotoxin Using Cell Surface Proteomics

Mary Ann Robinson, F. DeLeo, M. Robinson, 2010, PloS one.

TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity

M. Frank, T. Russo, M. Moffitt, 1993, Infection and immunity.

Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae.

K. Joiner, M. Frank, K. Warren, 1985, Journal of immunology.

Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.

K. Joiner, M. Frank, L. Leive, 1983, Journal of immunology.

Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from salmonella minnesota S218 without causing bacterial death

K. Joiner, M. Frank, L. Leive, 1982, The Journal of experimental medicine.

Quantitation of Radiolabeled Component Binding to Bacteria

K. Joiner, E. Brown, C. Hammer, 2003 .

MECHANISM OF SERUM RESISTANCE IN BACTERIA Serum

K. Joiner, E. Brown, M. Frank, 2003 .

Complement Deficiencies of Laboratory Animals

M. Frank, C. Hammer, T. Gaither, 1981 .

Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.

M. Shin, M. Mayer, C. Hammer, 1981, Journal of immunology.

Biotinylation of human C3.

M. Frank, M. Berger, C. Hammer, 1982, Molecular immunology.

Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.

K. Joiner, J. Schweinle, C. Hammer, 1989, Journal of immunology.

On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.

M. Mayer, C. Hammer, A. Nicholson, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.

M. Mayer, C. Hammer, H. Shin, 1974, Journal of immunology.

Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.

R. Eisenberg, G. Cohen, H. Friedman, 1986, Journal of immunology.

Isolation and characterization of a novel plasma protein which binds to activated C4 of the classical complement pathway.

M. Frank, C. Hammer, R. M. Jacobs, 1989, The Journal of biological chemistry.

Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement.

D. W. Michaels, A. Abramovitz, M. Mayer, 1976, Proceedings of the National Academy of Sciences of the United States of America.

C3d receptors are expressed on human monocytes after in vitro cultivation.

E. Brown, M. Frank, C. Hammer, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Quantitation of activation of the human terminal complement pathway by ELISA.

K. Joiner, M. Frank, M. Sanders, 1985, Journal of immunological methods.

Terminal complement components play a role in the expression of C5a.

H. Gresham, M. Frank, C. Hammer, 1987, Journal of immunology.

Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

C H Hammer, M. Shin, P. Vanguri, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.

A. Sher, K. Joiner, C. Hammer, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Studies of the molecular mechanisms of C3b inactivation and a simplified assay of beta 1H and the C3b inactivator (C3bINA).

M. Frank, C. Hammer, T. Gaither, 1979, Journal of immunology.

Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics.

M. Shin, C. Koski, M. Mayer, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Purification of the third component of canine complement.

J. Winkelstein, C. Hammer, J. Johnson, 1985, Veterinary immunology and immunopathology.

Regulation of complement activity by vaccinia virus complement-control protein.

B. Moss, M. Frank, G. Kotwal, 1992, The Journal of infectious diseases.

Immunologically mediated membrane damage: the mechanism of complement action and the similarity of lymphocyte-mediated cytotoxicity.

D. W. Michaels, M. Shin, M. Mayer, 1978, Transplantation proceedings.

A rapid FPLC method for purification of the third component of human and guinea pig complement.

C. Hammer, M. Basta, 1991, Journal of immunological methods.

Lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by acid-activated serum.

C. Hammer, G. Hänsch, U. Rother, 1983, Immunobiology.

Cleavage of membrane-bound C3b and C3bi by viable human neutrophils (PMN).

M. Frank, J. Gadek, C. Hammer, 1983, Molecular immunology.

Lack of binding of human C3, in its native state, to C3b receptors.

M. Frank, M. Berger, C. Hammer, 1981, Journal of immunology.

Avian riboflavinuria. 8. The fate of the riboflavin-binding protein-riboflavin complex during incubation of hen's eggs.

E. Buss, C. Hammer, C. O. Clagett, 1973, Poultry science.

Identification of Outer Membrane and Exoproteins of Carbapenem-Resistant Multilocus Sequence Type 258 Klebsiella pneumoniae

F. DeLeo, B. Kreiswirth, Liang Chen, 2015, PloS one.

Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.

H. Gresham, M. Shin, C. Hammer, 1983, Journal of immunology.

Avian renal riboflavinuria. 7. Riboflavin-binding protein transport and half-life.

E. Buss, K. McDonald, C. Hammer, 1971, Poultry Science.

Avian riboflavinuria IX. Qualitative action of a mutant gene in chicken on riboflavin-binding protein synthesis.

E. Buss, C. Hammer, C. O. Clagett, 1976, Genetics.

Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.

M. Meltzer, D. Hoover, M. Berger, 1985, Journal of immunology.

Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.

E. Brown, M. Frank, J. Ramsey, 1983, Journal of Immunology.

Serologic reactivity to the emerging pathogen Granulibacter bethesdensis.

S. Holland, D. Kuhns, D. Greenberg, 2012, The Journal of infectious diseases.

Mass-spectrometry assisted heavy-atom derivative screening of human FcγRIII crystals

C. Hammer, P. Sun, 2000 .